PK Study of Gefurulimab SC in Healthy Chinese Adult Participants
NCT06677138
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
gefurulimab
Sponsor
Alexion Pharmaceuticals, Inc.